MedTrace Logo

ATX-101 Abdominoplasty

NCT00835952 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2010-01-27

No results posted yet for this study

Summary

Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty

Conditions

  • Characteristics of Subcutaneous Fat

Interventions

DRUG

ATX-101

ATX-101 single doses

Sponsors & Collaborators

  • Kythera Biopharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Patricia Walker, M.D., Ph.D. · Kythera Biopharmaceuticals, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-03-31
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00835952 on ClinicalTrials.gov